Kowa Pharmaceuticals America Inc. Announces INTREPID Trial Results in The Lancet HIV Showing Superior LDL Cholesterol Reduction with LIVALOÂ pitavastatin Compared with Pravastatin in Adults with HIV and Dyslipidemia

INTREPID is first prospective randomized doubleblind activecontrolled headtohead statin trial evaluating the efficacy and safety of statin therapy in adults with HIV and dyslipidemia taking antiretroviral therapy Kowa Pharm...